Review



aldh1a2 rabbit polyclonal  (Cell Signaling Technology Inc)


Bioz Verified Symbol Cell Signaling Technology Inc is a verified supplier
Bioz Manufacturer Symbol Cell Signaling Technology Inc manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 93

    Structured Review

    Cell Signaling Technology Inc aldh1a2 rabbit polyclonal
    miR-138-5p overexpression partially regulates stem cell marker hTERT transcript levels, but does not alter another stem cell marker <t>ALDH1A2.</t> ( a ) Real-time PCR analysis of miR-138-5p after isolating total miRNAs from miR-138-5p transfected 250 nM FAC-treated cells relative to control transfected FAC-treated and Untreated FT194 cells, at days 122, 125 and 129 of FAC treatment (p = 35, 36, and 37) to validate the overexpression. ( b ) Western blotting was performed for cell lysates collected from miR-138-5p transfected and control transfected Untreated and FAC-treated FT194 cells to analyze ALDH1A2 levels at days 119, 122, and 126 of FAC treatment ( p = 35–37). White space between cropped blots delineate different antibody applications to the same blot. The full-length uncropped blots are displayed in the Supplementary Information File. ( c ) Western blotting was performed using cell lysates collected from control or miR-432-5p or miR-127-3p, transfected Untreated and FAC-treated FT194 cells with the indicated antibodies at days 123, 131, and 137 of FAC treatment ( p = 35, 37, and 38). White space between cropped blots delineate different antibody applications to the same blot. The full-length uncropped blots are displayed in the Supplementary Information File. ( d ) The predicted miR-138-5p binding site in the TERT sequence is shown. ( e ) Real-time PCR analysis of TERT in miR-138-5p transfected FAC-treated FT194 cells, relative to control transfected Untreated and FAC-treated FT194 cells after isolating miRNAs at days 119, 122, and 126 of FAC treatment ( p = 35–37). The data is the composite of three independent experiments.
    Aldh1a2 Rabbit Polyclonal, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 93/100, based on 12 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/aldh1a2 rabbit polyclonal/product/Cell Signaling Technology Inc
    Average 93 stars, based on 12 article reviews
    aldh1a2 rabbit polyclonal - by Bioz Stars, 2026-02
    93/100 stars

    Images

    1) Product Images from "Global miRNA/proteomic analyses identify miRNAs at 14q32 and 3p21, which contribute to features of chronic iron-exposed fallopian tube epithelial cells"

    Article Title: Global miRNA/proteomic analyses identify miRNAs at 14q32 and 3p21, which contribute to features of chronic iron-exposed fallopian tube epithelial cells

    Journal: Scientific Reports

    doi: 10.1038/s41598-021-85342-y

    miR-138-5p overexpression partially regulates stem cell marker hTERT transcript levels, but does not alter another stem cell marker ALDH1A2. ( a ) Real-time PCR analysis of miR-138-5p after isolating total miRNAs from miR-138-5p transfected 250 nM FAC-treated cells relative to control transfected FAC-treated and Untreated FT194 cells, at days 122, 125 and 129 of FAC treatment (p = 35, 36, and 37) to validate the overexpression. ( b ) Western blotting was performed for cell lysates collected from miR-138-5p transfected and control transfected Untreated and FAC-treated FT194 cells to analyze ALDH1A2 levels at days 119, 122, and 126 of FAC treatment ( p = 35–37). White space between cropped blots delineate different antibody applications to the same blot. The full-length uncropped blots are displayed in the Supplementary Information File. ( c ) Western blotting was performed using cell lysates collected from control or miR-432-5p or miR-127-3p, transfected Untreated and FAC-treated FT194 cells with the indicated antibodies at days 123, 131, and 137 of FAC treatment ( p = 35, 37, and 38). White space between cropped blots delineate different antibody applications to the same blot. The full-length uncropped blots are displayed in the Supplementary Information File. ( d ) The predicted miR-138-5p binding site in the TERT sequence is shown. ( e ) Real-time PCR analysis of TERT in miR-138-5p transfected FAC-treated FT194 cells, relative to control transfected Untreated and FAC-treated FT194 cells after isolating miRNAs at days 119, 122, and 126 of FAC treatment ( p = 35–37). The data is the composite of three independent experiments.
    Figure Legend Snippet: miR-138-5p overexpression partially regulates stem cell marker hTERT transcript levels, but does not alter another stem cell marker ALDH1A2. ( a ) Real-time PCR analysis of miR-138-5p after isolating total miRNAs from miR-138-5p transfected 250 nM FAC-treated cells relative to control transfected FAC-treated and Untreated FT194 cells, at days 122, 125 and 129 of FAC treatment (p = 35, 36, and 37) to validate the overexpression. ( b ) Western blotting was performed for cell lysates collected from miR-138-5p transfected and control transfected Untreated and FAC-treated FT194 cells to analyze ALDH1A2 levels at days 119, 122, and 126 of FAC treatment ( p = 35–37). White space between cropped blots delineate different antibody applications to the same blot. The full-length uncropped blots are displayed in the Supplementary Information File. ( c ) Western blotting was performed using cell lysates collected from control or miR-432-5p or miR-127-3p, transfected Untreated and FAC-treated FT194 cells with the indicated antibodies at days 123, 131, and 137 of FAC treatment ( p = 35, 37, and 38). White space between cropped blots delineate different antibody applications to the same blot. The full-length uncropped blots are displayed in the Supplementary Information File. ( d ) The predicted miR-138-5p binding site in the TERT sequence is shown. ( e ) Real-time PCR analysis of TERT in miR-138-5p transfected FAC-treated FT194 cells, relative to control transfected Untreated and FAC-treated FT194 cells after isolating miRNAs at days 119, 122, and 126 of FAC treatment ( p = 35–37). The data is the composite of three independent experiments.

    Techniques Used: Over Expression, Marker, Real-time Polymerase Chain Reaction, Transfection, Control, Western Blot, Binding Assay, Sequencing



    Similar Products

    90
    Bioss rabbit polyclonal anti aldh1a2 antibody
    Rabbit Polyclonal Anti Aldh1a2 Antibody, supplied by Bioss, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rabbit polyclonal anti aldh1a2 antibody/product/Bioss
    Average 90 stars, based on 1 article reviews
    rabbit polyclonal anti aldh1a2 antibody - by Bioz Stars, 2026-02
    90/100 stars
      Buy from Supplier

    93
    Proteintech rabbit polyclonal anti aldh1a2

    Rabbit Polyclonal Anti Aldh1a2, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rabbit polyclonal anti aldh1a2/product/Proteintech
    Average 93 stars, based on 1 article reviews
    rabbit polyclonal anti aldh1a2 - by Bioz Stars, 2026-02
    93/100 stars
      Buy from Supplier

    90
    Thermo Fisher aldh1a2 polyclonal antibody rabbit
    Whole-mount ISH for miR-133a and whole mount IMH for RhoA, Cdc42 and <t>Raldh2</t> during early chick cardiac development, from HH8–HH11 stages, in control embryos. Note miR-133a expression pattern at the level of the anterior region of the primitive endocardial tube (PET), being observable in the atrium (A) and ventricle (V) at later stages. Note the location of RhoA, Cdc42 and Raldh2 at the level of the PET posterior region, and subsequently in the atrium and inflow tract (IFT). The scheme illustrates the complementary location in cranial-caudal trend of miR-133a (blue) in comparison with RhoA, Cdc42 and Raldh2 (orange).
    Aldh1a2 Polyclonal Antibody Rabbit, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/aldh1a2 polyclonal antibody rabbit/product/Thermo Fisher
    Average 90 stars, based on 1 article reviews
    aldh1a2 polyclonal antibody rabbit - by Bioz Stars, 2026-02
    90/100 stars
      Buy from Supplier

    90
    Millipore rabbit polyclonal anti-aldh1a2
    KEY RESOURCES TABLE
    Rabbit Polyclonal Anti Aldh1a2, supplied by Millipore, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rabbit polyclonal anti-aldh1a2/product/Millipore
    Average 90 stars, based on 1 article reviews
    rabbit polyclonal anti-aldh1a2 - by Bioz Stars, 2026-02
    90/100 stars
      Buy from Supplier

    93
    Cell Signaling Technology Inc aldh1a2 rabbit polyclonal
    miR-138-5p overexpression partially regulates stem cell marker hTERT transcript levels, but does not alter another stem cell marker <t>ALDH1A2.</t> ( a ) Real-time PCR analysis of miR-138-5p after isolating total miRNAs from miR-138-5p transfected 250 nM FAC-treated cells relative to control transfected FAC-treated and Untreated FT194 cells, at days 122, 125 and 129 of FAC treatment (p = 35, 36, and 37) to validate the overexpression. ( b ) Western blotting was performed for cell lysates collected from miR-138-5p transfected and control transfected Untreated and FAC-treated FT194 cells to analyze ALDH1A2 levels at days 119, 122, and 126 of FAC treatment ( p = 35–37). White space between cropped blots delineate different antibody applications to the same blot. The full-length uncropped blots are displayed in the Supplementary Information File. ( c ) Western blotting was performed using cell lysates collected from control or miR-432-5p or miR-127-3p, transfected Untreated and FAC-treated FT194 cells with the indicated antibodies at days 123, 131, and 137 of FAC treatment ( p = 35, 37, and 38). White space between cropped blots delineate different antibody applications to the same blot. The full-length uncropped blots are displayed in the Supplementary Information File. ( d ) The predicted miR-138-5p binding site in the TERT sequence is shown. ( e ) Real-time PCR analysis of TERT in miR-138-5p transfected FAC-treated FT194 cells, relative to control transfected Untreated and FAC-treated FT194 cells after isolating miRNAs at days 119, 122, and 126 of FAC treatment ( p = 35–37). The data is the composite of three independent experiments.
    Aldh1a2 Rabbit Polyclonal, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/aldh1a2 rabbit polyclonal/product/Cell Signaling Technology Inc
    Average 93 stars, based on 1 article reviews
    aldh1a2 rabbit polyclonal - by Bioz Stars, 2026-02
    93/100 stars
      Buy from Supplier

    93
    Proteintech rabbit polyclonal proteintech
    miR-138-5p overexpression partially regulates stem cell marker hTERT transcript levels, but does not alter another stem cell marker <t>ALDH1A2.</t> ( a ) Real-time PCR analysis of miR-138-5p after isolating total miRNAs from miR-138-5p transfected 250 nM FAC-treated cells relative to control transfected FAC-treated and Untreated FT194 cells, at days 122, 125 and 129 of FAC treatment (p = 35, 36, and 37) to validate the overexpression. ( b ) Western blotting was performed for cell lysates collected from miR-138-5p transfected and control transfected Untreated and FAC-treated FT194 cells to analyze ALDH1A2 levels at days 119, 122, and 126 of FAC treatment ( p = 35–37). White space between cropped blots delineate different antibody applications to the same blot. The full-length uncropped blots are displayed in the Supplementary Information File. ( c ) Western blotting was performed using cell lysates collected from control or miR-432-5p or miR-127-3p, transfected Untreated and FAC-treated FT194 cells with the indicated antibodies at days 123, 131, and 137 of FAC treatment ( p = 35, 37, and 38). White space between cropped blots delineate different antibody applications to the same blot. The full-length uncropped blots are displayed in the Supplementary Information File. ( d ) The predicted miR-138-5p binding site in the TERT sequence is shown. ( e ) Real-time PCR analysis of TERT in miR-138-5p transfected FAC-treated FT194 cells, relative to control transfected Untreated and FAC-treated FT194 cells after isolating miRNAs at days 119, 122, and 126 of FAC treatment ( p = 35–37). The data is the composite of three independent experiments.
    Rabbit Polyclonal Proteintech, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rabbit polyclonal proteintech/product/Proteintech
    Average 93 stars, based on 1 article reviews
    rabbit polyclonal proteintech - by Bioz Stars, 2026-02
    93/100 stars
      Buy from Supplier

    93
    Proteintech rabbit polyclonal
    (A) Schematic of experiments for local recurrence (LR). Tumor-bearing KPCC mice were either amputated or focally irradiated. (B) Kaplan-Meier curve representing the percentage of mice and time to local recurrence following surgery. (C) Confocal microscopy images of locally recurrent tumor after surgery. GFP (green), YFP (yellow), RFP (red), CFP (cyan) (scale, 1 mm; inset scale, 100 μm). (D) Confocal microscopy images of recurrent tumor after irradiation (scale, 1 mm; inset scale, 100 μm). (E) Two <t>polyclonal</t> tumors were transplanted into multiple nude mice and stereotactic irradiation delayed tumor growth. The graph shows the effect of irradiation on tumor growth over time. Data represented as mean ± SD of relative tumor volume to starting tumor volume. (F) Confocal microscopy images of recurrent and control tumors after radiation therapy showed recurrence was driven by multiple clones. GFP(green), YFP (yellow), RFP (red), CFP (cyan), DAPI (blue) (scale, 50 μm).
    Rabbit Polyclonal, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rabbit polyclonal/product/Proteintech
    Average 93 stars, based on 1 article reviews
    rabbit polyclonal - by Bioz Stars, 2026-02
    93/100 stars
      Buy from Supplier

    90
    Proteintech rabbit polyclonal aldh1a2 antibody
    (A) Effect of stable overexpression of each candidate gene on the metastatic ability of KPCC cells after tail-vein injection. Each point represents the relative metastatic area in the lungs of an individual nude mouse. Data represented as mean ± SD (*p < 0.05, one-way ANOVA). (B) Metastatic burden following tail-vein injection of control or <t>Aldh1a2</t> overexpressing cells in an independent set of animals quantified by relative area of metastatic lesions. Data represented as mean ± SD (**p < 0.01, Student’s t test). (C) Representative H&E images of lungs from mice injected with Aldh1a2-OE and empty-vector control cells (scale, 1.5 mm). (D) Confocal lung metastasis after competition between Aldh1a2-OE (labeled green) and empty-vector control cells (labeled red) injected at 1:1 ratio into the tail vein of nude mice (scale, 1.5 mm; inset scale, 100 μm). (E) Quantification of metastases area. Data represented as mean ± SD (***p < 0.001, Student’s t test). (F) Confocal microscopy of orthotopic competition between Aldh1a2-OE cells (labeled green) and control cells (labeled red) injected at 1:1 ratio into the muscle of the extremity (scale, 700 μm; inset scale, 100 μm). (G) Quantification of tumor tissue area for each fluorescent reporter in tumor sections (Student’s t test).
    Rabbit Polyclonal Aldh1a2 Antibody, supplied by Proteintech, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rabbit polyclonal aldh1a2 antibody/product/Proteintech
    Average 90 stars, based on 1 article reviews
    rabbit polyclonal aldh1a2 antibody - by Bioz Stars, 2026-02
    90/100 stars
      Buy from Supplier

    93
    Proteintech antibody anti aldh1a2 rabbit polyclonal proteintech group
    (A) Effect of stable overexpression of each candidate gene on the metastatic ability of KPCC cells after tail-vein injection. Each point represents the relative metastatic area in the lungs of an individual nude mouse. Data represented as mean ± SD (*p < 0.05, one-way ANOVA). (B) Metastatic burden following tail-vein injection of control or <t>Aldh1a2</t> overexpressing cells in an independent set of animals quantified by relative area of metastatic lesions. Data represented as mean ± SD (**p < 0.01, Student’s t test). (C) Representative H&E images of lungs from mice injected with Aldh1a2-OE and empty-vector control cells (scale, 1.5 mm). (D) Confocal lung metastasis after competition between Aldh1a2-OE (labeled green) and empty-vector control cells (labeled red) injected at 1:1 ratio into the tail vein of nude mice (scale, 1.5 mm; inset scale, 100 μm). (E) Quantification of metastases area. Data represented as mean ± SD (***p < 0.001, Student’s t test). (F) Confocal microscopy of orthotopic competition between Aldh1a2-OE cells (labeled green) and control cells (labeled red) injected at 1:1 ratio into the muscle of the extremity (scale, 700 μm; inset scale, 100 μm). (G) Quantification of tumor tissue area for each fluorescent reporter in tumor sections (Student’s t test).
    Antibody Anti Aldh1a2 Rabbit Polyclonal Proteintech Group, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/antibody anti aldh1a2 rabbit polyclonal proteintech group/product/Proteintech
    Average 93 stars, based on 1 article reviews
    antibody anti aldh1a2 rabbit polyclonal proteintech group - by Bioz Stars, 2026-02
    93/100 stars
      Buy from Supplier

    Image Search Results


    Journal: iScience

    Article Title: Modification of lysine-260 2-hydroxyisobutyrylation destabilizes ALDH1A1 expression to regulate bladder cancer progression

    doi: 10.1016/j.isci.2023.108142

    Figure Lengend Snippet:

    Article Snippet: Rabbit polyclonal anti-ALDH1A2 , Proteintech , Cat #: 13951; RRID:AB_2224033.

    Techniques: Virus, Recombinant, Activity Assay, SYBR Green Assay, Software

    Whole-mount ISH for miR-133a and whole mount IMH for RhoA, Cdc42 and Raldh2 during early chick cardiac development, from HH8–HH11 stages, in control embryos. Note miR-133a expression pattern at the level of the anterior region of the primitive endocardial tube (PET), being observable in the atrium (A) and ventricle (V) at later stages. Note the location of RhoA, Cdc42 and Raldh2 at the level of the PET posterior region, and subsequently in the atrium and inflow tract (IFT). The scheme illustrates the complementary location in cranial-caudal trend of miR-133a (blue) in comparison with RhoA, Cdc42 and Raldh2 (orange).

    Journal: International Journal of Molecular Sciences

    Article Title: Inhibition of RhoA and Cdc42 by miR-133a Modulates Retinoic Acid Signalling during Early Development of Posterior Cardiac Tube Segment

    doi: 10.3390/ijms23084179

    Figure Lengend Snippet: Whole-mount ISH for miR-133a and whole mount IMH for RhoA, Cdc42 and Raldh2 during early chick cardiac development, from HH8–HH11 stages, in control embryos. Note miR-133a expression pattern at the level of the anterior region of the primitive endocardial tube (PET), being observable in the atrium (A) and ventricle (V) at later stages. Note the location of RhoA, Cdc42 and Raldh2 at the level of the PET posterior region, and subsequently in the atrium and inflow tract (IFT). The scheme illustrates the complementary location in cranial-caudal trend of miR-133a (blue) in comparison with RhoA, Cdc42 and Raldh2 (orange).

    Article Snippet: Experimental and control (CFDA) embryos were subjected to whole mount IMH was performed as previously described by us [ , ], using RhoA Polyclonal Antibody Rabbit (1:300, Invitrogen, OSR00266W), ALDH1A2 Polyclonal Antibody Rabbit (1:100, Invitrogen PA5-22377), followed by Goat anti-rabbit IgG-HRP antibody (1:1000, Upstate, 12-348) and Cdc42 monoclonal antibody Mouse (1:50, Santa-Cruz, sc-8401), followed by a Goat anti-mouse IgG-HRP antibody (1:200, Jackson Inmuno Research 115-035-003).

    Techniques: Expressing

    Effect of miR-133a gain- and loss-of-function on posterior cardiac segment. Whole-mount IMH for RhoA, Cdc42 and Raldh2. and ISH for Tbx5 and AMHC1. Embryos microinjected with CFDA (control), premiR-133a or antimiR-133a, at the level of the posterior cardiac precursors of both primitive endocardial tubes, and visualisation of CFDA ( A ). Note that, at the atrium and inflow tract levels, RhoA ( B ), Cdc42 ( C ), Raldh2 ( D ), Tbx5 ( E ) and AMHC1 ( F ) are dramatically reduced, and an atrophic sino-atrial region in the heart tube after premiR-133a treatment is indicated by the red arrows, whereas they are markedly increased and expanded after miR-133a inhibition (blue arrows). RT-qPCR of RNA from dissected cardiac asa (left side) in embryos microinjected either with CFDA, premiR-133a or antimiR-133a. A high level of miR-133a leads to decreased RhoA, Cdc42, Raldh2, Tbx5 and AMHC1 transcripts, whereas miR-133a inhibition leads to increased transcripts. The standard deviations are from three independent experiments. Student’s t -test: * p < 0.05, ** p < 0.01, *** p < 0.005 with respect to control (CFDA) embryos.

    Journal: International Journal of Molecular Sciences

    Article Title: Inhibition of RhoA and Cdc42 by miR-133a Modulates Retinoic Acid Signalling during Early Development of Posterior Cardiac Tube Segment

    doi: 10.3390/ijms23084179

    Figure Lengend Snippet: Effect of miR-133a gain- and loss-of-function on posterior cardiac segment. Whole-mount IMH for RhoA, Cdc42 and Raldh2. and ISH for Tbx5 and AMHC1. Embryos microinjected with CFDA (control), premiR-133a or antimiR-133a, at the level of the posterior cardiac precursors of both primitive endocardial tubes, and visualisation of CFDA ( A ). Note that, at the atrium and inflow tract levels, RhoA ( B ), Cdc42 ( C ), Raldh2 ( D ), Tbx5 ( E ) and AMHC1 ( F ) are dramatically reduced, and an atrophic sino-atrial region in the heart tube after premiR-133a treatment is indicated by the red arrows, whereas they are markedly increased and expanded after miR-133a inhibition (blue arrows). RT-qPCR of RNA from dissected cardiac asa (left side) in embryos microinjected either with CFDA, premiR-133a or antimiR-133a. A high level of miR-133a leads to decreased RhoA, Cdc42, Raldh2, Tbx5 and AMHC1 transcripts, whereas miR-133a inhibition leads to increased transcripts. The standard deviations are from three independent experiments. Student’s t -test: * p < 0.05, ** p < 0.01, *** p < 0.005 with respect to control (CFDA) embryos.

    Article Snippet: Experimental and control (CFDA) embryos were subjected to whole mount IMH was performed as previously described by us [ , ], using RhoA Polyclonal Antibody Rabbit (1:300, Invitrogen, OSR00266W), ALDH1A2 Polyclonal Antibody Rabbit (1:100, Invitrogen PA5-22377), followed by Goat anti-rabbit IgG-HRP antibody (1:1000, Upstate, 12-348) and Cdc42 monoclonal antibody Mouse (1:50, Santa-Cruz, sc-8401), followed by a Goat anti-mouse IgG-HRP antibody (1:200, Jackson Inmuno Research 115-035-003).

    Techniques: Inhibition, Quantitative RT-PCR

    Whole-mount ISH for miR-133a, Tbx5 , AMHC1 and IMH for Raldh2. Embryos microinjected with CFDA (control), Retinoic acid (RA) or Citral, at the level of the posterior cardiac precursors into both primitive endocardial tubes, and visualisation of CFDA ( A ). The gain-of-function of RA leads to diminished miR-133a expression (red arrows) at the cardiac asa level ( B ), accompanied by increased protein levels of Raldh2 ( C ) and expanded expression of Tbx5 ( D ) and AMHC1 ( E ) in the heart tube and in the inflow tract (blue arrows). Note atrophic sino-atrial region with increased miR-133a expression (blue arrows) at cardiac asa level ( B ), and also (red arrows) diminished Raldh2 protein level ( C ), and decreased Tbx5 ( D ) and AMHC1 ( E ) expressions by RA synthesis inhibition. RT-qPCR of RNA from dissected cardiac asa (left side) in embryos microinjected either with CFDA, RA or Citral. The standard deviations are from three independent experiments. Student’s t -test: * p < 0.05, ** p < 0.01, *** p < 0.005 with respect to control (CFDA) embryos.

    Journal: International Journal of Molecular Sciences

    Article Title: Inhibition of RhoA and Cdc42 by miR-133a Modulates Retinoic Acid Signalling during Early Development of Posterior Cardiac Tube Segment

    doi: 10.3390/ijms23084179

    Figure Lengend Snippet: Whole-mount ISH for miR-133a, Tbx5 , AMHC1 and IMH for Raldh2. Embryos microinjected with CFDA (control), Retinoic acid (RA) or Citral, at the level of the posterior cardiac precursors into both primitive endocardial tubes, and visualisation of CFDA ( A ). The gain-of-function of RA leads to diminished miR-133a expression (red arrows) at the cardiac asa level ( B ), accompanied by increased protein levels of Raldh2 ( C ) and expanded expression of Tbx5 ( D ) and AMHC1 ( E ) in the heart tube and in the inflow tract (blue arrows). Note atrophic sino-atrial region with increased miR-133a expression (blue arrows) at cardiac asa level ( B ), and also (red arrows) diminished Raldh2 protein level ( C ), and decreased Tbx5 ( D ) and AMHC1 ( E ) expressions by RA synthesis inhibition. RT-qPCR of RNA from dissected cardiac asa (left side) in embryos microinjected either with CFDA, RA or Citral. The standard deviations are from three independent experiments. Student’s t -test: * p < 0.05, ** p < 0.01, *** p < 0.005 with respect to control (CFDA) embryos.

    Article Snippet: Experimental and control (CFDA) embryos were subjected to whole mount IMH was performed as previously described by us [ , ], using RhoA Polyclonal Antibody Rabbit (1:300, Invitrogen, OSR00266W), ALDH1A2 Polyclonal Antibody Rabbit (1:100, Invitrogen PA5-22377), followed by Goat anti-rabbit IgG-HRP antibody (1:1000, Upstate, 12-348) and Cdc42 monoclonal antibody Mouse (1:50, Santa-Cruz, sc-8401), followed by a Goat anti-mouse IgG-HRP antibody (1:200, Jackson Inmuno Research 115-035-003).

    Techniques: Expressing, Inhibition, Quantitative RT-PCR

    Model proposed for the interplay between miR-133a and RA during posterior heart tube formation. Our model indicates that miR-133a downregulates RhoA and Cdc42. Consequently, Raldh2 downregulation is induced by miR-133a, via these Rho GTPases. RA synthesis is Raldh2-dependent. Thus, miR-133a modulates RA signalling via Raldh2 expression. Also, RA negatively modulates miR-133a expression during the early genetic programme of the sinoatrial region. Additionally, our model indicates that miR-133a modulates cell proliferation by acting on the cell cycle regulators p21 (via RhoA) and cyclin A (via Cdc42). We hypothesise that there is a negative feedback mechanism between miR-133a and RA signalling during early development of the posterior cardiac tube segment. A: anterior segment, P: posterior segment.

    Journal: International Journal of Molecular Sciences

    Article Title: Inhibition of RhoA and Cdc42 by miR-133a Modulates Retinoic Acid Signalling during Early Development of Posterior Cardiac Tube Segment

    doi: 10.3390/ijms23084179

    Figure Lengend Snippet: Model proposed for the interplay between miR-133a and RA during posterior heart tube formation. Our model indicates that miR-133a downregulates RhoA and Cdc42. Consequently, Raldh2 downregulation is induced by miR-133a, via these Rho GTPases. RA synthesis is Raldh2-dependent. Thus, miR-133a modulates RA signalling via Raldh2 expression. Also, RA negatively modulates miR-133a expression during the early genetic programme of the sinoatrial region. Additionally, our model indicates that miR-133a modulates cell proliferation by acting on the cell cycle regulators p21 (via RhoA) and cyclin A (via Cdc42). We hypothesise that there is a negative feedback mechanism between miR-133a and RA signalling during early development of the posterior cardiac tube segment. A: anterior segment, P: posterior segment.

    Article Snippet: Experimental and control (CFDA) embryos were subjected to whole mount IMH was performed as previously described by us [ , ], using RhoA Polyclonal Antibody Rabbit (1:300, Invitrogen, OSR00266W), ALDH1A2 Polyclonal Antibody Rabbit (1:100, Invitrogen PA5-22377), followed by Goat anti-rabbit IgG-HRP antibody (1:1000, Upstate, 12-348) and Cdc42 monoclonal antibody Mouse (1:50, Santa-Cruz, sc-8401), followed by a Goat anti-mouse IgG-HRP antibody (1:200, Jackson Inmuno Research 115-035-003).

    Techniques: Expressing

    KEY RESOURCES TABLE

    Journal: Cell reports

    Article Title: Cdc42 activity in Sertoli cells is essential for maintenance of spermatogenesis

    doi: 10.1016/j.celrep.2021.109885

    Figure Lengend Snippet: KEY RESOURCES TABLE

    Article Snippet: Rabbit polyclonal anti-ALDH1A2 , Sigma-Aldrich , Cat#HPA010022; RRID: AB_1844723.

    Techniques: Recombinant, Microarray, Real-time Polymerase Chain Reaction, Software

    miR-138-5p overexpression partially regulates stem cell marker hTERT transcript levels, but does not alter another stem cell marker ALDH1A2. ( a ) Real-time PCR analysis of miR-138-5p after isolating total miRNAs from miR-138-5p transfected 250 nM FAC-treated cells relative to control transfected FAC-treated and Untreated FT194 cells, at days 122, 125 and 129 of FAC treatment (p = 35, 36, and 37) to validate the overexpression. ( b ) Western blotting was performed for cell lysates collected from miR-138-5p transfected and control transfected Untreated and FAC-treated FT194 cells to analyze ALDH1A2 levels at days 119, 122, and 126 of FAC treatment ( p = 35–37). White space between cropped blots delineate different antibody applications to the same blot. The full-length uncropped blots are displayed in the Supplementary Information File. ( c ) Western blotting was performed using cell lysates collected from control or miR-432-5p or miR-127-3p, transfected Untreated and FAC-treated FT194 cells with the indicated antibodies at days 123, 131, and 137 of FAC treatment ( p = 35, 37, and 38). White space between cropped blots delineate different antibody applications to the same blot. The full-length uncropped blots are displayed in the Supplementary Information File. ( d ) The predicted miR-138-5p binding site in the TERT sequence is shown. ( e ) Real-time PCR analysis of TERT in miR-138-5p transfected FAC-treated FT194 cells, relative to control transfected Untreated and FAC-treated FT194 cells after isolating miRNAs at days 119, 122, and 126 of FAC treatment ( p = 35–37). The data is the composite of three independent experiments.

    Journal: Scientific Reports

    Article Title: Global miRNA/proteomic analyses identify miRNAs at 14q32 and 3p21, which contribute to features of chronic iron-exposed fallopian tube epithelial cells

    doi: 10.1038/s41598-021-85342-y

    Figure Lengend Snippet: miR-138-5p overexpression partially regulates stem cell marker hTERT transcript levels, but does not alter another stem cell marker ALDH1A2. ( a ) Real-time PCR analysis of miR-138-5p after isolating total miRNAs from miR-138-5p transfected 250 nM FAC-treated cells relative to control transfected FAC-treated and Untreated FT194 cells, at days 122, 125 and 129 of FAC treatment (p = 35, 36, and 37) to validate the overexpression. ( b ) Western blotting was performed for cell lysates collected from miR-138-5p transfected and control transfected Untreated and FAC-treated FT194 cells to analyze ALDH1A2 levels at days 119, 122, and 126 of FAC treatment ( p = 35–37). White space between cropped blots delineate different antibody applications to the same blot. The full-length uncropped blots are displayed in the Supplementary Information File. ( c ) Western blotting was performed using cell lysates collected from control or miR-432-5p or miR-127-3p, transfected Untreated and FAC-treated FT194 cells with the indicated antibodies at days 123, 131, and 137 of FAC treatment ( p = 35, 37, and 38). White space between cropped blots delineate different antibody applications to the same blot. The full-length uncropped blots are displayed in the Supplementary Information File. ( d ) The predicted miR-138-5p binding site in the TERT sequence is shown. ( e ) Real-time PCR analysis of TERT in miR-138-5p transfected FAC-treated FT194 cells, relative to control transfected Untreated and FAC-treated FT194 cells after isolating miRNAs at days 119, 122, and 126 of FAC treatment ( p = 35–37). The data is the composite of three independent experiments.

    Article Snippet: Western blotting was performed using the following Cell Signaling Technology (Danvers, MA, USA) primary antibodies: DNMT1 rabbit monoclonal (1:1000, #5032), EVI1 rabbit monoclonal (1:500, #2593), Pan-Actin rabbit polyclonal (1:1000, #4968), Acetyl Histone H3 (Lys9/Lys14) rabbit polyclonal (1:1000, #9677), ALDH1A2 rabbit polyclonal (1:1000, #83805), and CRYAB rabbit monoclonal (1:1000, #45844).

    Techniques: Over Expression, Marker, Real-time Polymerase Chain Reaction, Transfection, Control, Western Blot, Binding Assay, Sequencing

    (A) Schematic of experiments for local recurrence (LR). Tumor-bearing KPCC mice were either amputated or focally irradiated. (B) Kaplan-Meier curve representing the percentage of mice and time to local recurrence following surgery. (C) Confocal microscopy images of locally recurrent tumor after surgery. GFP (green), YFP (yellow), RFP (red), CFP (cyan) (scale, 1 mm; inset scale, 100 μm). (D) Confocal microscopy images of recurrent tumor after irradiation (scale, 1 mm; inset scale, 100 μm). (E) Two polyclonal tumors were transplanted into multiple nude mice and stereotactic irradiation delayed tumor growth. The graph shows the effect of irradiation on tumor growth over time. Data represented as mean ± SD of relative tumor volume to starting tumor volume. (F) Confocal microscopy images of recurrent and control tumors after radiation therapy showed recurrence was driven by multiple clones. GFP(green), YFP (yellow), RFP (red), CFP (cyan), DAPI (blue) (scale, 50 μm).

    Journal: Cell reports

    Article Title: Tracing Tumor Evolution in Sarcoma Reveals Clonal Origin of Advanced Metastasis

    doi: 10.1016/j.celrep.2019.08.029

    Figure Lengend Snippet: (A) Schematic of experiments for local recurrence (LR). Tumor-bearing KPCC mice were either amputated or focally irradiated. (B) Kaplan-Meier curve representing the percentage of mice and time to local recurrence following surgery. (C) Confocal microscopy images of locally recurrent tumor after surgery. GFP (green), YFP (yellow), RFP (red), CFP (cyan) (scale, 1 mm; inset scale, 100 μm). (D) Confocal microscopy images of recurrent tumor after irradiation (scale, 1 mm; inset scale, 100 μm). (E) Two polyclonal tumors were transplanted into multiple nude mice and stereotactic irradiation delayed tumor growth. The graph shows the effect of irradiation on tumor growth over time. Data represented as mean ± SD of relative tumor volume to starting tumor volume. (F) Confocal microscopy images of recurrent and control tumors after radiation therapy showed recurrence was driven by multiple clones. GFP(green), YFP (yellow), RFP (red), CFP (cyan), DAPI (blue) (scale, 50 μm).

    Article Snippet: Aldh1a2, Rabbit Polyclonal , ProteinTech , Cat#: 13951–1-AP; RRID:AB_2224033.

    Techniques: Irradiation, Confocal Microscopy, Control, Clone Assay

    (A) H&E (scale, 1 mm) and confocal images of monoclonal early metastatic lesions from a KPCC mouse (scale, 1 mm; inset scale, 100 μm). (B) H&E (scale, 1 mm) and confocal images of polyclonal early metastatic lesions from a KPCC mouse (scale, 1 mm; inset 1 scale, 50 μm; inset 2 scale, 100 μm). (C) Table indicating the number of tail-vein-injected mice that developed metastases for each sorted population and their totals (*p < 0.05, chi-square test comparing the number of mice with and without metastases between different clones). (D) H&E images of representative lung metastases from each sorted population (scale, 1 mm).

    Journal: Cell reports

    Article Title: Tracing Tumor Evolution in Sarcoma Reveals Clonal Origin of Advanced Metastasis

    doi: 10.1016/j.celrep.2019.08.029

    Figure Lengend Snippet: (A) H&E (scale, 1 mm) and confocal images of monoclonal early metastatic lesions from a KPCC mouse (scale, 1 mm; inset scale, 100 μm). (B) H&E (scale, 1 mm) and confocal images of polyclonal early metastatic lesions from a KPCC mouse (scale, 1 mm; inset 1 scale, 50 μm; inset 2 scale, 100 μm). (C) Table indicating the number of tail-vein-injected mice that developed metastases for each sorted population and their totals (*p < 0.05, chi-square test comparing the number of mice with and without metastases between different clones). (D) H&E images of representative lung metastases from each sorted population (scale, 1 mm).

    Article Snippet: Aldh1a2, Rabbit Polyclonal , ProteinTech , Cat#: 13951–1-AP; RRID:AB_2224033.

    Techniques: Injection, Clone Assay

    Journal: Cell reports

    Article Title: Tracing Tumor Evolution in Sarcoma Reveals Clonal Origin of Advanced Metastasis

    doi: 10.1016/j.celrep.2019.08.029

    Figure Lengend Snippet:

    Article Snippet: Aldh1a2, Rabbit Polyclonal , ProteinTech , Cat#: 13951–1-AP; RRID:AB_2224033.

    Techniques: Clone Assay, Virus, Plasmid Preparation, Software, Microscopy

    (A) Effect of stable overexpression of each candidate gene on the metastatic ability of KPCC cells after tail-vein injection. Each point represents the relative metastatic area in the lungs of an individual nude mouse. Data represented as mean ± SD (*p < 0.05, one-way ANOVA). (B) Metastatic burden following tail-vein injection of control or Aldh1a2 overexpressing cells in an independent set of animals quantified by relative area of metastatic lesions. Data represented as mean ± SD (**p < 0.01, Student’s t test). (C) Representative H&E images of lungs from mice injected with Aldh1a2-OE and empty-vector control cells (scale, 1.5 mm). (D) Confocal lung metastasis after competition between Aldh1a2-OE (labeled green) and empty-vector control cells (labeled red) injected at 1:1 ratio into the tail vein of nude mice (scale, 1.5 mm; inset scale, 100 μm). (E) Quantification of metastases area. Data represented as mean ± SD (***p < 0.001, Student’s t test). (F) Confocal microscopy of orthotopic competition between Aldh1a2-OE cells (labeled green) and control cells (labeled red) injected at 1:1 ratio into the muscle of the extremity (scale, 700 μm; inset scale, 100 μm). (G) Quantification of tumor tissue area for each fluorescent reporter in tumor sections (Student’s t test).

    Journal: Cell reports

    Article Title: Tracing Tumor Evolution in Sarcoma Reveals Clonal Origin of Advanced Metastasis

    doi: 10.1016/j.celrep.2019.08.029

    Figure Lengend Snippet: (A) Effect of stable overexpression of each candidate gene on the metastatic ability of KPCC cells after tail-vein injection. Each point represents the relative metastatic area in the lungs of an individual nude mouse. Data represented as mean ± SD (*p < 0.05, one-way ANOVA). (B) Metastatic burden following tail-vein injection of control or Aldh1a2 overexpressing cells in an independent set of animals quantified by relative area of metastatic lesions. Data represented as mean ± SD (**p < 0.01, Student’s t test). (C) Representative H&E images of lungs from mice injected with Aldh1a2-OE and empty-vector control cells (scale, 1.5 mm). (D) Confocal lung metastasis after competition between Aldh1a2-OE (labeled green) and empty-vector control cells (labeled red) injected at 1:1 ratio into the tail vein of nude mice (scale, 1.5 mm; inset scale, 100 μm). (E) Quantification of metastases area. Data represented as mean ± SD (***p < 0.001, Student’s t test). (F) Confocal microscopy of orthotopic competition between Aldh1a2-OE cells (labeled green) and control cells (labeled red) injected at 1:1 ratio into the muscle of the extremity (scale, 700 μm; inset scale, 100 μm). (G) Quantification of tumor tissue area for each fluorescent reporter in tumor sections (Student’s t test).

    Article Snippet: Aldh1a2, Rabbit Polyclonal , ProteinTech , Cat#: 13951–1-AP; RRID:AB_2224033.

    Techniques: Over Expression, Injection, Control, Plasmid Preparation, Labeling, Confocal Microscopy

    Journal: Cell reports

    Article Title: Tracing Tumor Evolution in Sarcoma Reveals Clonal Origin of Advanced Metastasis

    doi: 10.1016/j.celrep.2019.08.029

    Figure Lengend Snippet:

    Article Snippet: Aldh1a2, Rabbit Polyclonal , ProteinTech , Cat#: 13951–1-AP; RRID:AB_2224033.

    Techniques: Clone Assay, Virus, Plasmid Preparation, Software, Microscopy